Camurus Company
Camurus AB (publ) is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Founded Date:
1991-01-01
Last Funding Type:
Seed
Headquarters:
Sweden
Investors Number:
6
Technology:
Others
Employee Number:
11-50
Industry:
Stem Cell Exhaustion
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Investor Type:
For Profit
Total Funding:
€10.1M